Societe Generale cut shares of Koninklijke Philips (NYSE:PHG – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning, The Fly reports.
PHG has been the subject of a number of other research reports. Jefferies Financial Group cut Koninklijke Philips from a buy rating to a hold rating in a report on Tuesday, October 18th. StockNews.com started coverage on Koninklijke Philips in a report on Wednesday, October 12th. They set a hold rating for the company. HSBC cut Koninklijke Philips from a hold rating to a reduce rating in a report on Tuesday, October 25th. JPMorgan Chase & Co. lowered their target price on Koninklijke Philips from €18.80 ($20.43) to €10.90 ($11.85) in a report on Tuesday, November 1st. Finally, Oddo Bhf cut Koninklijke Philips from an outperform rating to a neutral rating and set a €17.00 ($18.48) target price for the company. in a report on Thursday, October 13th. Five investment analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Koninklijke Philips has a consensus rating of Hold and a consensus price target of $18.56.
Koninklijke Philips Price Performance
PHG opened at $17.71 on Tuesday. The business has a fifty day moving average of $15.57 and a 200 day moving average of $16.25. Koninklijke Philips has a 52-week low of $11.75 and a 52-week high of $34.93. The company has a quick ratio of 0.70, a current ratio of 1.29 and a debt-to-equity ratio of 0.55. The stock has a market cap of $15.75 billion, a P/E ratio of -11.39 and a beta of 0.88.
Institutional Inflows and Outflows
About Koninklijke Philips
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology.
- Get a free copy of the StockNews.com research report on Koninklijke Philips (PHG)
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- Insiders And Institutions Buy Wolverine Worldwide
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.